Exponent (EXPO) Competitors $72.92 +0.58 (+0.80%) Closing price 04:00 PM EasternExtended Trading$72.89 -0.03 (-0.05%) As of 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXPO vs. FCN, DNB, CBZ, VSEC, HURN, ICFI, CRAI, ACTG, FC, and MGShould you be buying Exponent stock or one of its competitors? The main competitors of Exponent include FTI Consulting (FCN), Dun & Bradstreet (DNB), CBIZ (CBZ), VSE (VSEC), Huron Consulting Group (HURN), ICF International (ICFI), Charles River Associates (CRAI), Acacia Research (ACTG), Franklin Covey (FC), and Mistras Group (MG). These companies are all part of the "research & consulting services" industry. Exponent vs. Its Competitors FTI Consulting Dun & Bradstreet CBIZ VSE Huron Consulting Group ICF International Charles River Associates Acacia Research Franklin Covey Mistras Group FTI Consulting (NYSE:FCN) and Exponent (NASDAQ:EXPO) are both mid-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Is FCN or EXPO more profitable? Exponent has a net margin of 18.87% compared to FTI Consulting's net margin of 7.14%. Exponent's return on equity of 25.33% beat FTI Consulting's return on equity.Company Net Margins Return on Equity Return on Assets FTI Consulting7.14% 13.07% 8.33% Exponent 18.87%25.33%14.10% Which has more risk & volatility, FCN or EXPO? FTI Consulting has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Do analysts prefer FCN or EXPO? FTI Consulting presently has a consensus target price of $175.50, suggesting a potential upside of 6.39%. Exponent has a consensus target price of $120.00, suggesting a potential upside of 64.56%. Given Exponent's stronger consensus rating and higher possible upside, analysts clearly believe Exponent is more favorable than FTI Consulting.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FTI Consulting 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Exponent 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, FCN or EXPO? FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFTI Consulting$3.70B1.53$280.09M$7.3122.57Exponent$558.51M6.63$109M$2.0535.57 Does the media favor FCN or EXPO? In the previous week, Exponent had 10 more articles in the media than FTI Consulting. MarketBeat recorded 16 mentions for Exponent and 6 mentions for FTI Consulting. FTI Consulting's average media sentiment score of 1.14 beat Exponent's score of 0.24 indicating that FTI Consulting is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FTI Consulting 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exponent 9 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of FCN or EXPO? 99.4% of FTI Consulting shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 1.8% of FTI Consulting shares are held by company insiders. Comparatively, 1.6% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryExponent beats FTI Consulting on 9 of the 15 factors compared between the two stocks. Get Exponent News Delivered to You Automatically Sign up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXPO vs. The Competition Export to ExcelMetricExponentConsulting IndustryBusiness SectorNASDAQ ExchangeMarket Cap$3.67B$7.53B$15.04B$9.31BDividend Yield1.66%1.67%2.73%4.03%P/E Ratio35.5724.9028.1719.73Price / Sales6.633.31569.41173.11Price / Cash30.9417.8926.3357.96Price / Book8.806.116.445.67Net Income$109M$272.15M$196.70M$257.79M7 Day Performance-1.71%1.52%0.50%0.52%1 Month Performance-3.81%3.46%5.42%8.84%1 Year Performance-31.17%-8.54%21.87%14.18% Exponent Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXPOExponent4.1213 of 5 stars$72.92+0.8%$120.00+64.6%-28.9%$3.67B$558.51M35.571,168FCNFTI Consulting4.1875 of 5 stars$167.11+1.8%$175.50+5.0%-26.2%$5.73B$3.67B22.868,374Positive NewsDNBDun & Bradstreet3.2493 of 5 stars$9.11-0.1%$11.86+30.2%-8.3%$4.06B$2.38B-182.106,247News CoverageCBZCBIZ3.1189 of 5 stars$72.90+0.9%$86.00+18.0%-7.5%$3.97B$2.16B49.5910,000VSECVSE2.9785 of 5 stars$129.58+2.3%$130.00+0.3%+38.6%$2.68B$1.17B161.981,400HURNHuron Consulting Group4.7799 of 5 stars$133.54+0.8%$170.75+27.9%+26.8%$2.30B$1.56B20.027,230Positive NewsICFIICF International4.6102 of 5 stars$87.80+0.3%$127.20+44.9%-36.4%$1.62B$2.02B15.069,300CRAICharles River Associates4.0442 of 5 stars$202.84+3.0%$228.00+12.4%+5.4%$1.38B$687.41M27.37940News CoverageAnalyst DowngradeHigh Trading VolumeACTGAcacia Research1.0674 of 5 stars$3.77-5.0%N/A-34.4%$362.57M$222.41M-34.271,036FCFranklin Covey3.86 of 5 stars$20.14+1.4%$31.00+53.9%-52.7%$254.57M$287.23M25.491,084MGMistras Group4.3111 of 5 stars$8.08-0.8%N/A-11.4%$252.99M$706.81M17.184,800 Related Companies and Tools Related Companies FTI Consulting Alternatives Dun & Bradstreet Alternatives CBIZ Alternatives VSE Alternatives Huron Consulting Group Alternatives ICF International Alternatives Charles River Associates Alternatives Acacia Research Alternatives Franklin Covey Alternatives Mistras Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXPO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exponent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exponent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.